CompoAtlas

NAZIDAR

Food supplement declared in France, declaration No 2023-7-1338, decision dated 25 July 2023

NAZIDAR is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
not provided
Food business operator placing the product on the market
LES TROIS CHENES
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2
Directions for use
Prendre 1 à 2 gélules par jour
Intended populations
Homme
Not recommended for (according to the manufacturer)
Antécédent de cancer du sein, Femmes enceintes, Sous antidépresseurs
Objectives stated by the manufacturer (these are not authorised claims)
Tonus sexuel

Declaration 303237, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Ptychopetalum olacoides Benth.EcorceExtrait sec aqueux45.5 mg
Astragalus membranaceus MoenchRacineExtrait sec aqueux28 mg
Crocus sativus L.StigmatesExtrait sec hydroalcoolique28 mg

Other active ingredients

NamePer day
L-Carnitine L-Tartratenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Levure enrichie en séléniumSélénium255 µg50 µg
L-pidolate de zincZinc25 mg15 mg

Additives

E460, E470b, E341

Other ingredients

Gélule végétale

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2023. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line